Suggestions
Claude Waddington
LinkedIn Top Leadership Voice in Pharma Digital Strategy
Claude Waddington is a prominent figure in the pharmaceutical and healthcare industry, serving as MD and Principal Consultant for ComEx Strategy at The Palindromic.2 He is recognized as a LinkedIn Top Leadership Voice in Pharma Digital Strategy.1
Waddington's career is driven by a mission to enhance healthcare decision-making processes and save lives through technology. His professional journey was inspired by the loss of his father to cancer, which led him to explore the intricacies of the healthcare system.
With a diverse background, Waddington has:
- Consulted for various SaaS platforms and major companies in ComEx, Medical Engagement, Omnichannel, and Data Analytics.
- Established Centers of Excellence (CoE) within major pharmaceutical enterprises.
- Collaborated with global agencies on digital strategies, medical education, and communication.
Waddington's expertise spans:
- Omnichannel engagement
- CRM and next-best-action solutions
- CLM/Marketing innovation
- Data and insights2
He advocates for a unified data model to bridge information silos and believes in the crucial role of digital transformation in revolutionizing care delivery. Waddington's academic background includes Bachelor's Degrees in Media, Visual Communications, and Psychology with Sociology, as well as a Diploma in Theological Studies.
As of February 2025, Waddington continues to be active in the industry, participating in webinars and sharing insights on topics such as AI-powered multimodal healthcare and omnichannel engagement strategies.345
Highlights
Only 4% of biopharma marketeers feel fully ready to deliver on their company's growth aspirations. Yet the demands placed on marketers by organizations are escalating. In the pursuit of immediate gains, brand teams neglect the opportunity to harness the power of strategic thinking and fully leverage available data and channels. This highlights the importance of balancing short-term objectives with long-term vision in order to achieve sustainable CX success. This is where the nuance between marketers and marketeers comes into place.
Physicians today face an overwhelming onslaught of email marketing campaigns, leaving them feeling inundated and struggling to discern which ones are truly worth their attention. This excessive bombardment makes it challenging for healthcare providers to separate valuable information from the noise, reducing the effectiveness of email marketing efforts.
Prioritizing time for strategic planning and innovation can help brand marketers break away from conventional methods, and uncover untapped potential, fostering much needed growth for their organizations and ensuring lasting impact in patient and physician engagement.
Rapidly evolving technology, an abundance of channels, and the ability to harness data and analytics can empower marketers to go beyond traditional brand-building responsibilities and revolutionize their impact on business growth. In sectors that swiftly adapt to these changes, marketers now play a pivotal role in driving revenue by leveraging digital tools to gain deep insights into customer experiences and develop strategies that optimize the lifetime value of every customer.
According to a McKinsey & Company study (The biopharma marketer of the future: Closing the gap) across 20 biopharmaceutical companies in the US, Europe & Japan, a mere 14% demonstrate an innovative approach to marketing. Furthermore, a dismal 21% are successfully capitalizing on the potential of emerging channels, suggesting a significant gap between opportunity and execution within the industry. These findings emphasize the untapped potential in fostering creative mindsets and effectively embracing new avenues for communication and growth.
To ensure success in Go-To-Market Strategy, biopharma businesses must address key pain points within their marketing ecosystem. This includes revamping people processes to recruit and develop essential skills, re-evaluating annual brand planning to foster agility, and streamlining approval procedures for new marketing materials. The current landscape, characterized by lengthy approval timelines and cumbersome planning, stifles marketers' ability to adapt to the rapid pace of digital communication, where they may need to send 50 distinct messages daily. Successful GTM strategies require an evolving and supportive ecosystem that empowers marketers to thrive and drive future growth.
#Keytruda #Ozempic #Dupixent #Eliquis #Biktarvy #omnichannel
China’s “Healthy China 2030” initiative is transforming healthcare delivery by addressing the escalating burden of non-communicable diseases through innovative strategies and cross-industry collaborations. With a focus on digital health, patient empowerment, and technology integration, China is setting a new standard for global healthcare.
As the world watches, the lessons from China’s approach could serve as a blueprint for nations worldwide to tackle similar challenges. In this article, I am exploring how this model is reshaping healthcare and what the global industry can learn from it.
#HealthcareInnovation #NCDs #HealthyChina2030 #DigitalHealth #China
